Tag Biosciences
Waisman Biomanufacturing has new managing director
Carl Ross has more than 26 years of experience advancing a wide range of cell and gene therapies, vaccines and therapeutic proteins into human clinical trials.
Attitudes on human genome editing vary, but all agree conversation is necessary
While about two-thirds of respondents expressed support for using gene editing to treat diseases, only one-third favored using the technology for enhancement, such as creating "designer babies."
Peanut family secret for making chemical building blocks revealed
As you bite into your next peanut butter and jelly sandwich, chew on this: The peanut you’re eating has a secret.
D-Day invasion was bolstered by UW–Madison penicillin project
By discovering new strains, isolating more productive mutants, and improving growing methods, UW biologists helped supply Allied troops with enough penicillin to treat life-threatening infections.
Zika infections could be factor in more pregnancies
“It’s sobering," says researcher Ted Golos. "If microcephaly is the tip of the iceberg for babies infected in pregnancy, the rest of the iceberg may be bigger than we’ve imagined.”
UW-Madison biochemist wins Shaw Scientist Award
Ophelia Venturelli's research may lead to the ability to engineer behaviors among beneficial microbes in the gut ecosystem, which could be used to enhance their resilience to invasion by pathogens or unintended impairment from antibiotics.
As continents continue moving, study suggests effects on biodiversity
UW geoscientists have found that marine species tend to become more numerous when the continents divide, and to stabilize — maybe even decline — when continents congeal.
Enzyme structures illuminate mechanism behind bacteria’s bioremediation prowess
The work is important because it provides a glimpse of the mechanics of a process that could be harnessed to help clean up oil spills and create valuable new chemicals.
Listeria may be serious miscarriage threat early in pregnancy
Listeria makes about 1,600 Americans sick each year — a relatively small number, but a group heavy on newborn babies and older adults with undeveloped or weak immune systems.
From mice, clues to microbiome’s influence on metabolic disease
The microorganisms that reside in the gut work in tandem with the genes of a host organism to regulate insulin secretion, a key variable in the onset of diabetes.
Gut’s microbial community shown to influence host gene expression
The upshot of the study is another indictment of the so-called Western diet, high in saturated fats, sugar and red meat.
UW-Madison technology enlisted in battle against hepatitis B
A method that emerged from a UW–Madison spinoff company is in clinical trials in Europe, Asia and the United States against the infection, which can destroy the liver.
UW-Madison spinoff gets FDA OK for bacteria-killing wound dressing
Microlyte, patented by Imbed Biosciences, will compete in the $2 billion market sector of "advanced wound dressings," which are used to treat ulcers, burns, bedsores and other difficult wounds.
Mitochondrial maps reveal new connections to poorly understood diseases
Mitochondrial diseases strike about 1 in 4,000 people and there are currently no licensed therapies available beyond treatments with vitamins and supplements.
Tiny 3-D models may yield big insights into ovarian cancer
With a unique approach that draws on 3-D printing technologies, a team of UW–Madison researchers is developing new tools for understanding how ovarian cancer develops in women.
UW, Purdue scientists solve structure of cold virus linked to childhood asthma
The findings provide the foundation for future antiviral drug and vaccine development against rhinovirus C.
UW biotech spinoff Mirus Bio celebrates two decades in business
The company makes cutting-edge products based on discoveries by three UW scientists for delivering DNA and RNA into cells.
Research may point to new ways to deliver drugs into bacteria
The results were surprising due to the breadth of the different proteins found to be involved, says biochemist Douglas Weibel.
Cancer treatment spinoff takes top honor in life science at Governor’s Business Plan Contest
Lynx Biosciences is developing technology to choose the drug most likely to benefit a blood cancer patient by analyzing how the tumor cells respond.
Chemistry lessons from bacteria may improve biofuel production
Enzymes are one of the most expensive parts of making biofuels. UW researchers say if they can identify enzymes that work better, it could lead to cheaper energy.